<code id='6B9F17AC47'></code><style id='6B9F17AC47'></style>
    • <acronym id='6B9F17AC47'></acronym>
      <center id='6B9F17AC47'><center id='6B9F17AC47'><tfoot id='6B9F17AC47'></tfoot></center><abbr id='6B9F17AC47'><dir id='6B9F17AC47'><tfoot id='6B9F17AC47'></tfoot><noframes id='6B9F17AC47'>

    • <optgroup id='6B9F17AC47'><strike id='6B9F17AC47'><sup id='6B9F17AC47'></sup></strike><code id='6B9F17AC47'></code></optgroup>
        1. <b id='6B9F17AC47'><label id='6B9F17AC47'><select id='6B9F17AC47'><dt id='6B9F17AC47'><span id='6B9F17AC47'></span></dt></select></label></b><u id='6B9F17AC47'></u>
          <i id='6B9F17AC47'><strike id='6B9F17AC47'><tt id='6B9F17AC47'><pre id='6B9F17AC47'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:72823
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Free speech concerns arise in wake of journal editor Eisen's firing
          Free speech concerns arise in wake of journal editor Eisen's firing

          MichaelEisen,whowasfiredaseditor-in-chiefofeLife.CourtesyNoahBerger/AP/HHMIPioneeringlifesciencesjou

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Sanofi CEO defends move to abandon profit guidance, boost research

          SanofiCEOPaulHudsonCarolynKaster/APLONDON—SanofiCEOPaulHudsononWednesdaydefendedhiscompany’srecentmo